UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 12b-25

 

NOTIFICATION OF LATE FILING

 

(Check One): ¨ Form 10-K  x Form 20-F  ¨ Form 11-K  ¨ Form 10-Q  ¨ Form 10-D  ¨ Form N-CEN  ¨  Form N-CSR

 

For Period Ended: December 31, 2020

 

¨ Transition Report on Form 10-K
¨ Transition Report on Form 20-F
¨ Transition Report on Form 11-K
¨ Transition Report on Form 10-Q

 

For the Transition Period Ended: _____________________________________

 

PART I – REGISTRANT INFORMATION

 

New Frontier Health Corporation

Full Name of Registrant:

 

N/A

Former Name if Applicable:

 

10 Jiuxianqiao Road, Hengtong Business Park, B7 Building, 1/F

Address of Principal Executive Office (Street and number):

 

Chaoyang District, Beijing, China 100015

City, State and Zip Code

 

PART II – RULES 12b-25(b) AND (c)

 

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed (Check box if appropriate)

 

  (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
     
x (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
     
  (c) The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 

 

 

 

 

 

PART III – NARRATIVE

 

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

 

New Frontier Health Corporation (the “Company”) was unable, without unreasonable effort or expense, to file its Annual Report on Form 20-F for the fiscal year ended December 31, 2020 (the “Annual Report”) by April 30, 2021, the filing date applicable to foreign private issuers, due to a delay experienced by the Company in completing its financial statements and other related disclosures in the Annual Report in light of the April 12, 2021 statement (the “SEC Statement”) released by the Staff of the Securities and Exchange Commission relating to the accounting and reporting considerations for warrants issued by special purpose acquisition companies (“SPACs”) and former SPACs, like the Company. Specifically, the Company needs more time to incorporate the revised accounting treatment required by the SEC Statement for its warrants in its financial statements.

 

The Company anticipates that it will file the Annual Report no later than the fifteenth calendar day following the prescribed filing date.

 

PART IV – OTHER INFORMATION

 

(1) Name and telephone number of person to contact in regard to this notification:

 

  Roberta Lipson   +86 10   59277000
  (Name)   (Area Code)   (Telephone Number)

  

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).

 

x Yes  ¨ No

 

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

 

 ¨ Yes  x No

 

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

  

  New Frontier Health Corporation  
  (Name of Registrant as Specified in Charter)  

 

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: April 30, 2021  By:   /s/ Roberta Lipson
      Name: Roberta Lipson
      Title: Chief Executive Officer

 

   

 

 

New Frontier Health (NYSE:NFH)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more New Frontier Health Charts.
New Frontier Health (NYSE:NFH)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more New Frontier Health Charts.